Literature DB >> 12391470

Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine.

A Sethi1, D Chandra, V Puri, V Mallika.   

Abstract

52 patients (25 males and 27 females) suffering from refrectory partial seizures, of not more than two years duration and on carbamazepine monotherapy were enrolled in this study. Patients were randomly put on gabapentin (19 males and 8 females) or lamotrigine (6 males and 19 females) as add on therapy. The efficacy of the drugs was assessed by the seizure frequency, pattern of seizures and seizure free interval. The safety was evaluated from the biochemical investigations and the adverse effects observed or reported by the patients during the course of the study. The average frequency of basal partial seizures was 6.26+3.86 and 5.04+2.47 which decreased significantly (p<. 001) after 12 weeks of add on therapy to 1.75+2.16. and 1.68+2.94 in the GBP and LTG group respectively. However, there was no significant difference between the two drugs after 12 weeks of add on therapy. The PCB (primary change in basal seizure frequency) values decreased to -72+34.92 and -76.22+29.68 in the GBP and LTG group respectively. The difference in these two groups was not significant. The responder rate was 77.7% and 92% respectively in GBP and LTG group respectively. GBP was found to be more effective in partial seizures with secondarily generalization while LTG was effective in all subtypes of partial seizures. The abnormal scalp EEG was recorded in 33.3% (9 of 27 patients) in GBP group and 40 %( 10 of 25 patients) in LTG group and it did not revert to normal in 33.3% and 40% of patients in either of groups (GBP/LTG). Minor side effects which were self limiting were noticed in 80% in groups I and 74% were groups II.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391470

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  6 in total

Review 1.  [Patients with epilepsy and anxiety disorders. Diagnosis and treatment].

Authors:  S Beyenburg; D Schmidt
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

2.  Gabapentin add-on treatment for drug-resistant focal epilepsy.

Authors:  Mariangela Panebianco; Sarah Al-Bachari; Jane L Hutton; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2021-01-12

3.  A comprehensive review of the literature on epilepsy in selected countries in emerging markets.

Authors:  Mallik Angalakuditi; Nupur Angalakuditi
Journal:  Neuropsychiatr Dis Treat       Date:  2011-09-29       Impact factor: 2.570

4.  Antiepileptic drugs prescription utilization behavior and direct costs of treatment in a national hospital of India.

Authors:  Ahsan Haroon; Manjari Tripathi; R Khanam; Divya Vohora
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383

5.  Gabapentin add-on treatment for drug-resistant focal epilepsy.

Authors:  Mariangela Panebianco; Sarah Al-Bachari; Jennifer Weston; Jane L Hutton; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2018-10-24

6.  Lamotrigine add-on therapy for drug-resistant focal epilepsy.

Authors:  Mariangela Panebianco; Rebecca Bresnahan; Sridharan Ramaratnam; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2020-03-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.